Welcome to our dedicated page for Marimed news (Ticker: MRMD), a resource for investors and traders seeking the latest updates and insights on Marimed stock.
Marimed Inc. (MRMD) operates as a vertically integrated cannabis company with a regulated seed-to-sale approach across multiple states. This page aggregates official press releases and verified news about the company’s cultivation practices, product innovations, and market expansions.
Investors and industry professionals will find timely updates on MRMD’s operational milestones, including regulatory compliance developments, retail dispensary openings, and wholesale distribution partnerships. The curated collection includes earnings reports, leadership announcements, and strategic initiatives shaping the company’s position in the cannabis sector.
Key content categories cover facility certifications, new market entries, product line expansions, and compliance achievements. All materials reflect MRMD’s commitment to operating within strict regulatory frameworks while maintaining product consistency through GMP-certified production processes.
Bookmark this page for direct access to primary-source information about Marimed’s operational and financial developments. Check regularly for updates impacting the company’s performance in evolving cannabis markets.
MariMed, a leading multi-state cannabis operator, has received approval to commence adult-use retail sales at its Panacea Wellness dispensary in Quincy, Massachusetts. This makes it MariMed's third adult-use dispensary in the state, hitting the maximum allowed by law. The Quincy location began adult-use sales on July 2, 2024, offering a variety of products including Nature's Heritage flower and concentrates, Betty's Eddies fruit chews, and Bubby's Baked goods.
Additionally, MariMed announced regulatory updates in Ohio and Maryland. They received a provisional dual-use license for recreational sales in Tiffin, Ohio, pending final state inspection. In Maryland, MariMed received approval to operate a newly expanded cultivation facility in Hagerstown and expects to commence operations at a second Thrive dispensary in Upper Marlboro later this month.
These developments are expected to positively impact MariMed's future operational and financial results.
MariMed has completed the acquisition of Our Community Wellness & Compassionate Care Center in Prince George's County, Maryland, effective April 5th. This dispensary, closed since July 1st, 2023, will reopen for adult-use cannabis sales by the end of the second quarter, pending regulatory approval. MariMed paid the state’s adult-use conversion fee and obtained the necessary retail license from the Maryland Cannabis Administration. This acquisition marks the company's second adult-use Thrive Wellness dispensary in Maryland. MariMed also operates a dispensary in Annapolis and a cultivation and processing facility in Hagerstown. The company plans further acquisitions to reach the state-allowed maximum of four dispensaries. The new Upper Marlboro location will feature MariMed’s branded products, including Nature’s Heritage, Betty’s Eddies, Bubby’s Baked, and Vibations.
MariMed Inc. reported strong financial results for the first quarter of 2024, with revenue reaching $37.9 million and a positive adjusted EBITDA for the 17th consecutive quarter. The company outperformed its competition in all markets, including Illinois, with significant growth in its wholesale business. MariMed also announced key operational highlights, such as expanding its branded products in Illinois, opening a new dispensary in Maryland, and forming partnerships with Boston music venues. The company's 2024 financial targets include revenue growth of 5-7% and non-GAAP Adjusted EBITDA growth of 0-2%.
MariMed Inc. CEO Jon Levine praises the DEA's decision to move cannabis to Schedule III, highlighting benefits for consumers, patients, communities, investors, and the industry. The reclassification will ease research, boost product innovation, remove tax burdens, and potentially open up financial opportunities.
FAQ
What is the current stock price of Marimed (MRMD)?
What is the market cap of Marimed (MRMD)?
